Decomposing the Value of a Pharmaceutical Firm

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.20, Iss.2, 2006-01, pp. : 87-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The `drug Value' in the European Pharmaceutical System

By Benzi G. Ceci A.

Pharmacological Research, Vol. 37, Iss. 5, 1998-05 ,pp. : 333-337

Academic Press

Access to resources Recommend Favorite

Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain

By Darba J.

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1211-1212

Adis International

Access to resources Recommend Favorite

Metabolomics and Its Practical Value in Pharmaceutical Industry

Current Drug Metabolism, Vol. 12, Iss. 4, 2011-05 ,pp. : 345-358

Bentham Science Publishers

Access to resources Recommend Favorite

Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing?

By Gerber Andreas

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 549-553

Adis International

Access to resources Recommend Favorite

Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes

By Morrison Alan Levy Richard

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 673-689

Future Medicine

Access to resources Recommend Favorite